Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters











Database
Language
Publication year range
1.
Brief Bioinform ; 24(5)2023 09 20.
Article in English | MEDLINE | ID: mdl-37738400

ABSTRACT

Implementing a specific cloud resource to analyze extensive genomic data on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses a challenge when resources are limited. To overcome this, we repurposed a cloud platform initially designed for use in research on cancer genomics (https://cgc.sbgenomics.com) to enable its use in research on SARS-CoV-2 to build Cloud Workflow for Viral and Variant Identification (COWID). COWID is a workflow based on the Common Workflow Language that realizes the full potential of sequencing technology for use in reliable SARS-CoV-2 identification and leverages cloud computing to achieve efficient parallelization. COWID outperformed other contemporary methods for identification by offering scalable identification and reliable variant findings with no false-positive results. COWID typically processed each sample of raw sequencing data within 5 min at a cost of only US$0.01. The COWID source code is publicly available (https://github.com/hendrick0403/COWID) and can be accessed on any computer with Internet access. COWID is designed to be user-friendly; it can be implemented without prior programming knowledge. Therefore, COWID is a time-efficient tool that can be used during a pandemic.


Subject(s)
COVID-19 , Humans , COVID-19/diagnosis , Cloud Computing , SARS-CoV-2/genetics , Workflow , Genomics
2.
J Cloud Comput (Heidelb) ; 12(1): 10, 2023.
Article in English | MEDLINE | ID: mdl-36691661

ABSTRACT

Supporting security and data privacy in cloud workflows has attracted significant research attention. For example, private patients' data managed by a workflow deployed on the cloud need to be protected, and communication of such data across multiple stakeholders should also be secured. In general, security threats in cloud environments have been studied extensively. Such threats include data breaches, data loss, denial of service, service rejection, and malicious insiders generated from issues such as multi-tenancy, loss of control over data and trust. Supporting the security of a cloud workflow deployed and executed over a dynamic environment, across different platforms, involving different stakeholders, and dynamic data is a difficult task and is the sole responsibility of cloud providers. Therefore, in this paper, we propose an architecture and a formal model for security enforcement in cloud workflow orchestration. The proposed architecture emphasizes monitoring cloud resources, workflow tasks, and the data to detect and predict anomalies in cloud workflow orchestration using a multi-modal approach that combines deep learning, one class classification, and clustering. It also features an adaptation scheme to cope with anomalies and mitigate their effect on the workflow cloud performance. Our prediction model captures unsupervised static and dynamic features as well as reduces the data dimensionality, which leads to better characterization of various cloud workflow tasks, and thus provides better prediction of potential attacks. We conduct a set of experiments to evaluate the proposed anomaly detection, prediction, and adaptation schemes using a real COVID-19 dataset of patient health records. The results of the training and prediction experiments show high anomaly prediction accuracy in terms of precision, recall, and F1 scores. Other experimental results maintained a high execution performance of the cloud workflow after applying adaptation strategy to respond to some detected anomalies. The experiments demonstrate how the proposed architecture prevents unnecessary wastage of resources due to anomaly detection and prediction.

3.
Genes (Basel) ; 13(4)2022 04 13.
Article in English | MEDLINE | ID: mdl-35456492

ABSTRACT

Several variants of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are emerging all over the world. Variant surveillance from genome sequencing has become crucial to determine if mutations in these variants are rendering the virus more infectious, potent, or resistant to existing vaccines and therapeutics. Meanwhile, analyzing many raw sequencing data repeatedly with currently available code-based bioinformatics tools is tremendously challenging to be implemented in this unprecedented pandemic time due to the fact of limited experts and computational resources. Therefore, in order to hasten variant surveillance efforts, we developed an installation-free cloud workflow for robust mutation profiling of SARS-CoV-2 variants from multiple Illumina sequencing data. Herein, 55 raw sequencing data representing four early SARS-CoV-2 variants of concern (Alpha, Beta, Gamma, and Delta) from an open-access database were used to test our workflow performance. As a result, our workflow could automatically identify mutated sites of the variants along with reliable annotation of the protein-coding genes at cost-effective and timely manner for all by harnessing parallel cloud computing in one execution under resource-limitation settings. In addition, our workflow can also generate a consensus genome sequence which can be shared with others in public data repositories to support global variant surveillance efforts.


Subject(s)
COVID-19 , SARS-CoV-2 , COVID-19/genetics , High-Throughput Nucleotide Sequencing , Humans , Mutation , SARS-CoV-2/genetics , Spike Glycoprotein, Coronavirus/genetics , Workflow
4.
Biology (Basel) ; 10(10)2021 Oct 11.
Article in English | MEDLINE | ID: mdl-34681121

ABSTRACT

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has recently become a novel pandemic event following the swine flu that occurred in 2009, which was caused by the influenza A virus (H1N1 subtype). The accurate identification of the huge number of samples during a pandemic still remains a challenge. In this study, we integrate two technologies, next-generation sequencing and cloud computing, into an optimized workflow version that uses a specific identification algorithm on the designated cloud platform. We use 182 samples (92 for COVID-19 and 90 for swine flu) with short-read sequencing data from two open-access datasets to represent each pandemic and evaluate our workflow performance based on an index specifically created for SARS-CoV-2 or H1N1. Results show that our workflow could differentiate cases between the two pandemics with a higher accuracy depending on the index used, especially when the index that exclusively represented each dataset was used. Our workflow substantially outperforms the original complete identification workflow available on the same platform in terms of time and cost by preserving essential tools internally. Our workflow can serve as a powerful tool for the robust identification of cases and, thus, aid in controlling the current and future pandemics.

SELECTION OF CITATIONS
SEARCH DETAIL